Fny Investment Advisers, LLC Neurocrine Biosciences Inc Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
$68.32 - $124.36 $136,640 - $248,720
-2,000 Closed
0 $0
Q3 2018

Oct 29, 2018
BUY
$98.88 - $125.85 $98,880 - $125,850
1,000 Added 100.0%
2,000 $245,000
Q2 2018

Jul 18, 2018
BUY
$75.3 - $105.99 $75,300 - $105,990
1,000 New
1,000 $98,000

Others Institutions Holding NBIX

# of Institutions
624
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email